Merck receives patent for CRISPR tech in China – MarketWatch
Mirage News |
Merck receives patent for CRISPR tech in China
MarketWatch Merck KGaA (MRK.XE) said Monday that it has received a patent for its CRISPR genome-editing technology in China. The CRISPR technology allows for precise chromosome modification in living cells, said Merck. Its applications range "from identifying … MilliporeSigma Receives Patent for CRISPR Technology in China Merck Receives Patent for CRISPR Technology in China |
